This company has shut down. BioStrand is no longer operating — its last tracked round was a Grant in 2022.
Explore the Startup GraveyardBioStrand is advancing technology for analyzing genetic data, which will drive innovation in the fields of precision medicine.
BioStrand has raised $486K in total funding. The most recent round was Grant. The last funding was announced in May 2022.
BioStrand's investors include Agentschap Innoveren & Ondernemen, K & E.
BioStrand is headquartered in Diepenbeek, Belgium.
BioStrand is advancing technology for analyzing genetic data, which will drive innovation in the fields of precision medicine.
BioStrand is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioStrand — Funding & Investors." VCBacked, May 9, 2022, https://www.vcbacked.co/company/biostrand. Accessed August 14, 2026.
VCBacked. (2022). BioStrand — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/biostrand
{{cite web |title=BioStrand — Funding & Investors |url=https://www.vcbacked.co/company/biostrand |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated